Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Clinuvel Pharmaceuticals Ltd ADR (CUVL)

$7.40 +0.05 (0.68%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	N/A
Revenue (ttm)	0.00
Net Income (ttm)	0.00
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	N/A

Volume	18,800
Avg Vol	3,478
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	37%
Beta	N/A
Analysts	Strong Buy
Price Target	N/A

CLINUVEL implements strategic reorganisation to refocus on U.S. markets

Mon, 20 Jul 2026 01:37:00 -0400 - 3 days ago

CLINUVEL's ADS to commence trading on Nasdaq

2026-07-13T14:51:13.000Z - 10 days ago

Clinuvel Receives Compliance To Market SCENESSE In Canada For Treating Phototoxicity

Jul 13, 2026, 1:10 AM EDT - 10 days ago

SCENESSE® approved for EPP in Canada

Apr 24, 2026, 1:47 AM EDT - 3 months ago

CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study

Apr 15, 2026, 2:18 AM EDT - 3 months ago

CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026

Feb 26, 2026, 2:00 AM EST - 5 months ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H1 2026

Feb 26, 2026, 2:00 AM EST - 5 months ago

Clinuvel Pharmaceuticals Quarterly report: H1 2026

Feb 26, 2026, 2:00 AM EST - 5 months ago

Clinuvel Pharmaceuticals Slides: H1 2026

Feb 26, 2026, 2:00 AM EST - 5 months ago

Clinuvel Pharmaceuticals Earnings release: H1 2026

Dec 7, 2025, 9:37 PM EST - 8 months ago

CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies

Nov 13, 2025, 6:00 PM EST - 8 months ago

Clinuvel Pharmaceuticals Slides: Investor Presentation

Sep 28, 2025, 10:56 PM EDT - 10 months ago

CLINUVEL to advance novel pharmaceutical formulations in preclinical program

Aug 28, 2025, 3:00 AM EDT - 11 months ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2025

Aug 28, 2025, 3:00 AM EDT - 11 months ago

Clinuvel Pharmaceuticals Annual report: H2 2025

Aug 28, 2025, 3:00 AM EDT - 11 months ago

Clinuvel Pharmaceuticals Slides: H2 2025

Aug 28, 2025, 3:00 AM EDT - 11 months ago

Clinuvel Pharmaceuticals Earnings release: H2 2025

Aug 22, 2025, 3:43 AM EDT - 11 months ago

CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist

Jun 24, 2025, 2:00 AM EDT - 1 year ago

Clinuvel Pharmaceuticals Slides: Investor Presentation

May 7, 2025, 12:10 AM EDT - 1 year ago

CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105

Mar 3, 2025, 9:17 PM EST - 1 year ago

Clinuvel Introduces Groundbreaking Vitiligo Program at the World's Biggest Dermatology Meeting, AAD 2025

Feb 27, 2025, 2:00 AM EST - 1 year ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H1 2025

Feb 27, 2025, 2:00 AM EST - 1 year ago

Clinuvel Pharmaceuticals Quarterly report: H1 2025

Feb 27, 2025, 2:00 AM EST - 1 year ago

Clinuvel Pharmaceuticals Slides: H1 2025

Feb 27, 2025, 2:00 AM EST - 1 year ago

Clinuvel Pharmaceuticals Earnings release: H1 2025

Oct 15, 2024, 6:30 PM EDT - 1 year ago

Clinuvel Pharmaceuticals Transcript: AGM 2024

Oct 15, 2024, 6:30 PM EDT - 1 year ago

Clinuvel Pharmaceuticals Slides: FY 2024

Sep 30, 2024, 7:07 PM EDT - 1 year ago

CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP

Aug 29, 2024, 4:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2024

Aug 29, 2024, 4:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Annual report: H2 2024

Aug 29, 2024, 4:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Slides: H2 2024

Aug 29, 2024, 4:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Earnings release: H2 2024

Jun 17, 2024, 8:39 PM EDT - 2 years ago

Afamelanotide in fair-skinned Parkinson's patients

May 1, 2024, 7:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Slides: Investor Presentation

Mar 28, 2024, 4:25 AM EDT - 2 years ago

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors

Mar 4, 2024, 9:38 PM EST - 2 years ago

Malibu shines a light on CLINUVEL's pioneering work in photomedicine

Feb 22, 2024, 2:00 AM EST - 2 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H1 2024

Feb 22, 2024, 2:00 AM EST - 2 years ago

Clinuvel Pharmaceuticals Quarterly report: H1 2024

Feb 22, 2024, 2:00 AM EST - 2 years ago

Clinuvel Pharmaceuticals Earnings release: H1 2024

Oct 31, 2023, 3:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Slides: FY 2023

Oct 1, 2023, 8:00 PM EDT - 3 years ago

Clinuvel Pharmaceuticals Transcript: Status Update

Aug 29, 2023, 4:00 AM EDT - 3 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2023

Aug 29, 2023, 4:00 AM EDT - 3 years ago

Clinuvel Pharmaceuticals Annual report: H2 2023

Aug 29, 2023, 4:00 AM EDT - 3 years ago

Clinuvel Pharmaceuticals Earnings release: H2 2023

Feb 28, 2023, 6:58 PM EST - 3 years ago

CLINUVEL Launches CYACÊLLE, Next Generation Solar Care

Feb 23, 2023, 8:00 PM EST - 3 years ago

Clinuvel Pharmaceuticals Quarterly report: H1 2023

Feb 23, 2023, 8:00 PM EST - 3 years ago

Clinuvel Pharmaceuticals Earnings release: H1 2023

Feb 23, 2023, 6:14 PM EST - 3 years ago

Global SCENESSE® demand drives increased CLINUVEL revenues, earnings

Feb 1, 2023, 7:14 PM EST - 3 years ago

CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals

Jan 15, 2023, 6:23 PM EST - 3 years ago

CLINUVEL Trial Results Show Drug Reduces DNA Damage

Aug 31, 2022, 3:30 AM EDT - 4 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2022

Aug 31, 2022, 3:30 AM EDT - 4 years ago

Clinuvel Pharmaceuticals Annual report: H2 2022

Aug 31, 2022, 3:30 AM EDT - 4 years ago

Clinuvel Pharmaceuticals Earnings release: H2 2022

Aug 31, 2022, 3:30 AM EDT - 4 years ago

Clinuvel Pharmaceuticals Slides: H2 2022

May 9, 2022, 9:33 PM EDT - 4 years ago

CLINUVEL progresses vitiligo treatment program

May 3, 2022, 8:24 PM EDT - 4 years ago

Positive final results in stroke

Apr 29, 2022, 1:20 AM EDT - 4 years ago

Letter to shareholders from CLINUVEL's CEO

Feb 23, 2022, 12:00 PM EST - 4 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H1 2022

Feb 23, 2022, 12:00 PM EST - 4 years ago

Clinuvel Pharmaceuticals Quarterly report: H1 2022

Feb 23, 2022, 12:00 PM EST - 4 years ago

Clinuvel Pharmaceuticals Earnings release: H1 2022

Nov 7, 2021, 11:03 PM EST - 5 years ago

CLINUVEL Expands Pharmaceutical Portfolio

Aug 25, 2021, 8:00 PM EDT - 5 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2021

Aug 25, 2021, 8:00 PM EDT - 5 years ago

Clinuvel Pharmaceuticals Annual report: H2 2021

Aug 25, 2021, 8:00 PM EDT - 5 years ago

Clinuvel Pharmaceuticals Earnings release: H2 2021

Aug 25, 2021, 8:00 PM EDT - 5 years ago

Clinuvel Pharmaceuticals Slides: H2 2021

Mar 23, 2021, 8:10 PM EDT - 5 years ago

CLINUVEL expands DNA Repair Program

1.0.0